These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8554969)

  • 1. Phase II study of gemcitabine in patients with advanced pancreatic cancer.
    Carmichael J; Fink U; Russell RC; Spittle MF; Harris AL; Spiessi G; Blatter J
    Br J Cancer; 1996 Jan; 73(1):101-5. PubMed ID: 8554969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced breast cancer: a phase II trial with gemcitabine.
    Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
    J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine in advanced breast cancer.
    Possinger K
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():55-9. PubMed ID: 8718426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients.
    Lund B; Hansen OP; Neijt JP; Theilade K; Hansen M
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():61-2. PubMed ID: 8718427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer.
    Tomao S; Romiti A; Massidda B; Ionta MT; Farris A; Zullo A; Brescia A; Santuari L; Frati L
    Anticancer Res; 2002; 22(4):2361-4. PubMed ID: 12174927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
    Anderson H; Lund B; Bach F; Thatcher N; Walling J; Hansen HH
    J Clin Oncol; 1994 Sep; 12(9):1821-6. PubMed ID: 8083706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study.
    Gatzemeier U; Shepherd FA; Le Chevalier T; Weynants P; Cottier B; Groen HJ; Rosso R; Mattson K; Cortes-Funes H; Tonato M; Burkes RL; Gottfried M; Voi M
    Eur J Cancer; 1996 Feb; 32A(2):243-8. PubMed ID: 8664035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gemcitabine in elderly patients with unresectable pancreas cancer].
    Hanada K; Hino F; Amano H; Ooe H; Hirota Y; Sasao S; Obayashi M; Kajiyama G
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2521-5. PubMed ID: 12506475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial.
    Van Kooten M; Traine G; Cinat G; Cazap E; Comba AZ; Vicente H; Sena S; Nievas OR; Orlando M
    Br J Cancer; 1999 Nov; 81(5):846-9. PubMed ID: 10555756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine: safety profile unaffected by starting dose.
    Martin C; Pollera CF
    Int J Clin Pharmacol Res; 1996; 16(1):9-18. PubMed ID: 9001925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II activity of gemcitabine in advanced breast cancer.
    Carmichael J; Walling J
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):77-81. PubMed ID: 8893887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A phase II multicenter study of gemcitabine in non small cell lung cancers].
    Le Chevalier T; Gottfried M; Gatzemeier U; Shepherd F; Weynants P; Cottier B; Groen HJ; Rosso R; Mattson K; Cortes-Funes H; Tonato M; Burkes RL; Voi M; Ponzio A
    Bull Cancer; 1997 Mar; 84(3):282-8. PubMed ID: 9207875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
    Hidalgo M; Castellano D; Paz-Ares L; Gravalos C; Diaz-Puente M; Hitt R; Alonso S; Cortes-Funes H
    J Clin Oncol; 1999 Feb; 17(2):585-92. PubMed ID: 10080603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile of gemcitabine.
    Tonato M; Mosconi AM; Martin C
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():27-32. PubMed ID: 8718422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine in advanced pancreatic cancer: a phase II trial.
    Crinò L; Mosconi AM; Calandri C; Corgna E; Porrozzi S; Chiara S; Nobili MT; Tonato M
    Am J Clin Oncol; 2001 Jun; 24(3):296-8. PubMed ID: 11404504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
    Takada M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Fukuoka M
    Cancer Chemother Pharmacol; 1998; 41(3):217-22. PubMed ID: 9443638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].
    Tendo M; Nakata B; Nishino H; Inoue M; Kosaka K; Amano R; Yamada N; Hirakawa K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):795-8. PubMed ID: 15984518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.
    Scheithauer W; Kornek GV; Raderer M; Hejna M; Valencak J; Miholic J; Kovats E; Lang F; Funovics J; Bareck E; Depisch D
    Br J Cancer; 1999 Aug; 80(11):1797-802. PubMed ID: 10468299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of gemcitabine in patients with advanced pancreatic cancer.
    Okada S; Ueno H; Okusaka T; Ikeda M; Furuse J; Maru Y
    Jpn J Clin Oncol; 2001 Jan; 31(1):7-12. PubMed ID: 11256843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
    de Lange SM; van Groeningen CJ; Meijer OW; Cuesta MA; Langendijk JA; van Riel JM; Pinedo HM; Peters GJ; Meijer S; Slotman BJ; Giaccone G
    Eur J Cancer; 2002 Jun; 38(9):1212-7. PubMed ID: 12044508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.